Target intelligence / Profile preview

MicroRNA 378d-2 (MIR378D2)

Target
MIR378D2
Molecular classification
MicroRNA, Non-coding RNA
01

Overview

MicroRNA 378d-2 is a member of the miR-378 family, which is a group of small, highly conserved non-coding RNAs present in many tissues. miR-378 family members regulate gene expression by binding to the 3' untranslated region of mRNAs in a sequence-specific manner, resulting in mRNA degradation or translational repression[2][4]. The family plays key roles in the regulation of cell proliferation, apoptosis, differentiation, angiogenesis, and metabolism[1][2][3][4]. Aberrant expression of miR-378 family miRNAs has been linked to tumor development, progression, metastasis, and cardiovascular disease. Serum or tissue levels of miR-378 family miRNAs can function as diagnostic or prognostic biomarkers for several cancers, including renal cell carcinoma, colorectal, and cervical cancer[2][3]. However, explicit references to MIR378D2 (microRNA 378d-2) in mainstream scientific databases and publications are extremely limited or absent; literature focuses on more well-studied isoforms within the miR-378 family, such as miR-378a. There is no evidence for "microRNA 378d-2" (MIR378D2) as a distinct, widely-recognized gene or target in current standard scientific databases and literature. The miR-378 family, however, is thoroughly characterized and relevant to several diseases[4][5]. Data above is adapted from broader miR-378 family studies; specific details may not apply to miR-378d-2 alone if its existence or function is not verified.

Other names
hsa-mir-378d-2mir-378d-2miR-378d-2
02

Biological functions

Regulation of apoptosisCell differentiationCell proliferationAngiogenesisStress response
03

Disease associations

Cancer (various types: liver, renal cell carcinoma, cervical, non-small cell lung, glioma, colorectal, gastric)Cardiovascular disease (myocardial infarction, heart failure, coronary heart disease)Metabolic diseases (brown adipose tissue expansion, lipogenesis)
04

Safety considerations

Off-target effects due to pleiotropic regulation of genesTissue- and context-dependent effects (may suppress or promote tumorigenesis depending on cancer type and cellular environment)
05

Biomarkers

Elevated or decreased serum/plasma levels of miR-378 (not specifically miR-378d-2) are biomarkers for cancer diagnosis, prognosis, and monitoring therapeutic response—particularly in renal cell carcinoma and colorectal cancer

Beyond the preview

Go deeper on MicroRNA 378d-2 (MIR378D2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 378d-2 (MIR378D2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call